E-LIB Suche - Ergebnisse für: Degeling, Koen

1

PRIMCAT-CRC: a data-driven whole disease simulation model f..:

Degeling, Koen ; To, Yat Hang ; Trapani, Karen...
Value in Health. , 2024

Link: https://doi.org/10.1016/..

2

Implementing competing risks in discrete event simulation: ..:

Franchini, Fanny ; Fedyashov, Victor ; IJzerman, Maarten J..
Frontiers in Pharmacology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

3

Cost Effectiveness of Molecular Diagnostic Testing Algorith..:

Vu, Martin ; Degeling, Koen ; Thompson, Ella R....
Applied Health Economics and Health Policy. 22 (2023) 1 - p. 107-122 , 2023

Link: https://doi.org/10.1007/..

4

Health economic evidence for adjuvant chemotherapy in stage..:

To, Yat Hang ; Gibbs, Peter ; Tie, Jeanne..
Cost Effectiveness and Resource Allocation. 21 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

5

Circulating Tumour DNA Guided Adjuvant Chemotherapy Decisio..:

To, Yat Hang ; Gibbs, Peter ; Tie, Jeanne...
Cancers. 15 (2023) 21 - p. 5227 , 2023

Link: https://doi.org/10.3390/..

6

Quantifying the impact of novel metastatic cancer therapies..:

Zebrowska, Karolina ; Banuelos, Rosa C. ; Rizzo, Evelyn J....
Frontiers in Pharmacology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

7

OP168 Costs And Effectiveness Of Whole Exome Sequencing (WE..:

Marshall, Deborah A ; Degeling, Koen ; Tagimacruz, Toni...
International Journal of Technology Assessment in Health Care. 39 (2023) S1 - p. S50-S50 , 2023

Link: https://doi.org/10.1017/..

8

Comparing Survival Outcomes for Advanced Cancer Patients Wh..:

O'Haire, Sophie ; Degeling, Koen ; Franchini, Fanny...
Targeted Oncology. 17 (2022) 5 - p. 539-548 , 2022

Link: https://doi.org/10.1007/..

9

Comparing Modeling Approaches for Discrete Event Simulation..:

Degeling, Koen ; IJzerman, Maarten J. ; Groothuis-Oudshoorn, Catharina G.M....
Value in Health. 25 (2022) 1 - p. 104-115 , 2022

Link: https://doi.org/10.1016/..

10

Real‐world adjuvant chemotherapy treatment patterns and out..:

To, Yat Hang ; Degeling, Koen ; McCoy, Melanie...
Asia-Pacific Journal of Clinical Oncology. 19 (2022) 3 - p. 392-402 , 2022

Link: https://doi.org/10.1111/..

11

Can we increase efficiency of CT lung cancer screening by c..:

Behr, Carina M. ; Koffijberg, Hendrik ; Degeling, Koen..
European Radiology. 32 (2022) 5 - p. 3067-3075 , 2022

Link: https://doi.org/10.1007/..

12

Health economic evidence for the use of molecular biomarker..:

Vu, Martin ; Degeling, Koen ; Thompson, Ella R....
European Journal of Haematology. 108 (2022) 6 - p. 469-485 , 2022

Link: https://doi.org/10.1111/..

13

Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung..:

Koole, Simone N. ; Vessies, Daan C. L. ; Schuurbiers, Milou M. F....
Cancers. 14 (2022) 7 - p. 1783 , 2022

Link: https://doi.org/10.3390/..

14

Lifetime Health and Economic Outcomes of Active Surveillanc..:

Degeling, Koen ; Corcoran, Niall M. ; Pereira-Salgado, Amanda...
Value in Health. 24 (2021) 12 - p. 1737-1745 , 2021

Link: https://doi.org/10.1016/..

15

Health Economic Evidence for Liquid- and Tissue-based Molec..:

Degeling, Koen ; Pereira-Salgado, Amanda ; Corcoran, Niall M....
European Urology Open Science. 27 (2021) - p. 77-87 , 2021

Link: https://doi.org/10.1016/..